Webster Brian Daniel 4
4 · KESTRA MEDICAL TECHNOLOGIES, LTD. · Filed Dec 31, 2025
Insider Transaction Report
Form 4
Webster Brian Daniel
DirectorSee Remarks
Transactions
- Sale
Common Shares
2025-12-29$26.59/sh−15,000$398,847→ 409,786 total
Footnotes (3)
- [F1]The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.
- [F2]The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.390 to $26.9504. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.
- [F3]Includes 27,209 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.